insights_auto
Why is AGIO down २.९२%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २९.२७
arrow_downward
-२.९२%(-०.८८) 1D
नोभेम्बर १७, ११:१९:४३ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ ३०.०९
High
US$ ३०.३८
Low
US$ २८.९४
Mkt. cap
१.७५ अरब
Avg. vol.
१२.३३ लाख
Volume
१.१० लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ ३०.०९
High
US$ ३०.३८
Low
US$ २८.९४
Mkt. cap
१.७५ अरब
Avg. vol.
१२.३३ लाख
Volume
१.१० लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
ChartMill
·
४४ मिनेट पहिले
S&P 500 Stocks Gapping Down in Today's Session
TradingView
·
१ घण्टा पहिले
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
qz.com
·
४ घण्टा पहिले
5 Nasdaq-linked stock indexes and how each differs from the S&P 500
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc